Navigation Links
Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year 2009 Results; Teleconference and Webcast to be held on September 8, 2009
Date:9/4/2009

CRANBURY, N.J., Sept. 4 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its fourth quarter and fiscal year 2009 financial results on Tuesday, September 8, 2009, before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on September 8, 2009, which will include discussion of the results of operations in greater detail and an update on corporate developments.

    Schedule for the Financial Results Press Release, Conference Call/Webcast

    - Q4 & Fiscal Year 2009 Financial Results
       Press Release                                 9/8/2009 at 7:30 a.m. ET

    - Q4 & Fiscal Year 2009 Conference Call-Live     9/8/2009 at 11:00 a.m. ET
      Domestic Dial-In Number                        1-800-776-0816
      International Dial-In Number                   1-913-312-0854
      Passcode                                       1405577

    - Q4 & Fiscal Year 2009 Conference Call-Replay   9/8-9/15/2009
      Domestic Dial-In Number                        1-888-203-1112
      International Dial-In Number                   1-719-457-0820
      Passcode                                       1405577

    - Webcast Live and Replay Access                http://www.palatin.com

      The webcast and replay can be accessed by logging on to the
      "Investor/Media Center-Webcasts" section of Palatin's website at
     http://www.palatin.com

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on d
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
2. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
3. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
4. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
5. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
6. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
7. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
8. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
9. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
10. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
11. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... supplement? InVitria has what scientists have been asking for! Zap-CHO ... the growth and productivity of CHO cells. Developed for scientists ... free, well defined and consistent recombinant CHO supplement. , ... ... 2009 -- Scientists working with CHO cells can now access ...
(Date:12/16/2009)... introduces HSP-A Soy Peptone. HSP A has been found to ... ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ... Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), ... improve growth rates and yields. HSP-A has been found to ...
(Date:12/15/2009)... Dec. 15 Epeius Biotechnologies Corporation, an ... medicine, gained international validation of the cutting-edge science ... when scientists around the world rediscovered the ... locus of cancer pathogenesis and disease progression, and ... scientists at the NIH National Cancer Institute investigating ...
(Date:12/15/2009)... Repligen Corporation (Nasdaq: RGEN ) today announced ... funding to support the ongoing development of new ... Association (MDA). This grant will support the ... manufacture of a drug candidate for human clinical ... provides important funding for Repligen,s research but it ...
Breaking Biology Technology:Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3
... German . , In this information age, ... and technology. A team of German and Italian researchers ... storage domains". As the scientists, led by Massimiliano Cavallini ... and Mario Ruben at the Forschungszentrum Karlsruhe (Germany), report ...
... Pa., Oct. 27 BioTrends Research Group, Inc.,released ... from 204 Nephrologists and 201 Renal Dietitians in ... of the management of dialysis,patients, particularly in their ... Vitamin D, and Calcimimetic agents., In the ...
... Jersey, October 27, Rosetta Genomics Ltd. (Nasdaq: ROSG ... and therapeutics, today,announced that Credit Suisse, as part ... Attorney General of the State of New York ... has begun to,repurchase Rosetta Genomics ARS. So far, ...
Other Biology Technology:Progress toward new storage media 2BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics 2Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics 3
(Date:12/15/2009)... The mouse is a standard laboratory model organism, ... conventional techniques to analyze blood and blood-forming tissues ... of compact and easy-to-use laboratory resources from Cold ... Mouse Hematology features step-by-step protocols for ... blood, bone marrow, and other hematopoietic tissues in ...
(Date:12/14/2009)... molecule in a freeze-tolerant Alaska beetle able to survive ... described biological antifreezes that contain protein, this new molecule, ... composed of a sugar and a fatty acid and ... organisms. , "The most exciting part of this ... kind of antifreeze that may work in a different ...
(Date:12/14/2009)... most comprehensive study to date of the proteins in ... provide important clues to how similar regeneration could be ... of Science at Indiana University-Purdue University Indianapolis and colleagues ... of axolotls, a type of salamander that has the ... of amputation, with the hope that this knowledge will ...
Breaking Biology News(10 mins):New source of classical techniques for blood-based studies in the laboratory mouse 2Scientists isolate new antifreeze molecule in Alaska beetle 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 1CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 2CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 3CPC Strengthens Foundation as a Closure Products Company with its Vertically Integrated Product Pipeline 48279 4The Worlds Smallest Hero 21 Rexin G Targeted Therapy for Metastatic Cancers 12540 1The Worlds Smallest Hero 21 Rexin G Targeted Therapy for Metastatic Cancers 12540 2Computers Causing Injuries in the Home 48275 1Computers Causing Injuries in the Home 48275 2Computers Causing Injuries in the Home 48275 3
... created technology to regrow teeth--the first time scientists have ... low-intensity pulsed ultrasound (LIPUS), Dr. Tarak El-Bialy from the ... and Dr. Ying Tsui from the Faculty of Engineering ... and novel way to stimulate jaw growth and dental ...
... be blocked by pain medications such as Advil and ... understood, a Queen's University study has found. , "The ... we classify the commonly used anti-inflammatory and pain drugs ... professor of Biochemistry and Physiology at Queen's and Canada ...
... Noel Dahl and Mohammad F. Islam have made a ... disease that accelerates the aging process by about seven ... of chemical and biomedical engineering at Carnegie Mellon, said ... of the National Institutes of Health (NIH), the John ...
Other Biology News:Ultrasound may help regrow teeth 2New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds 2Carnegie Mellon researchers discover new cell properties 2
... 48 lanes, 24 bi-directional, of patient DNA ... either slab gel or capillary sequencers, using ... parameters in Explorer have been sealed to ... have built Explorer for ease of use, ...
... Quality ISO 9001:2000 Certified USDA Research ... Validated, SOP's Training AALAS Certified ... All Procedures GLP Documentation Upon Request ... shopping point for all your custom immunology ...
...
Peptide-affinity Purified Polyclonal Antibody to Sphingolipid Receptor Edg8/S1P5...
Biology Products: